US Regional Director of Medical Affairs GYN Malignancies
MSD
About this role
The US Director of Medical Affairs for Gynecologic Malignancies is responsible for developing and implementing regional oncology Medical Affairs strategies and providing scientific and medical expertise within the US for Gynecological Cancers. The role involves collaboration with internal teams and external stakeholders to support product development, education, and stakeholder engagement.
Skills
About MSD
msd.comAt MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Recent company news
Vietnam Investment Review - VIRMSD reaffirms long-term commitment to Vietnam's healthcare sector
3 hours ago
Onco'ZineASCO GU: How Merck & Co/MSD is Advancing Treatment of Bladder and Kidney Cancers
3 weeks ago
WAVE NewsLouisville Water Company, MSD honor 96 veterans during annual breakfast
Nov 7, 2025
Pharmaceutical TechnologyMSD ends takeover talks with Revolution Medicines
1 month ago
CNBCExclusive Interview with BDT & MSD Partners Co-CEOs
Nov 19, 2025
About MSD
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for MSD.
Salary
$210k – $331k
per year
More jobs at MSD
Similar Jobs
Senior Director, Global Medical Oncology, Pumitamig GI/GU Cancers
0468 BMS Polska Sp. z o.o.
Medical Affairs Senior Director, Oncology – Colorectal Cancer
Takeda Pharmaceutical Company
Senior Director, Medical Affairs
CSL Innovation
US Medical Affairs- Medical Lead
American Association of Physicists in Medicine
Senior Director, US Medical Affairs Strategy Lead - GI
Revolution Medicines
Medical Director, Oncology Clinical Development
GSK plc